NEULAND LABORATORIES
Back to Income Statement
|
NEULAND LABORATORIES Last 5 Year Consolidated Net Profit History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Consolidated Net Profit | ₹64 Cr | ₹81 Cr | ₹16 Cr | ₹16 Cr | ₹12 Cr |
What is the latest Consolidated Net Profit of NEULAND LABORATORIES ?
Year | Consolidated Net Profit |
---|---|
Mar2023 | ₹64 Cr |
Mar2022 | ₹81 Cr |
Mar2021 | ₹16 Cr |
Mar2020 | ₹16 Cr |
Mar2019 | ₹12 Cr |
How is Consolidated Net Profit of NEULAND LABORATORIES Trending?
Years | Consolidated Net Profit | % Change | |
---|---|---|---|
Mar2023 | ₹64 Cr | -20.85 | |
Mar2022 | ₹81 Cr | 397.38 | |
Mar2021 | ₹16 Cr | -1.40 | |
Mar2020 | ₹16 Cr | 36.30 | |
Mar2019 | ₹12 Cr | - |
Compare Consolidated Net Profit of peers of NEULAND LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NEULAND LABORATORIES | ₹9,652.1 Cr | 8% | 20.3% | 258.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹361,916.0 Cr | 0.3% | -7.5% | 53.9% | Stock Analytics | |
CIPLA | ₹115,034.0 Cr | 1.1% | -4.8% | 56.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,929.0 Cr | 1.6% | 1.6% | 27.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹104,873.0 Cr | -1.9% | 10.7% | 21.4% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹100,322.0 Cr | 5.2% | -0.2% | 90.1% | Stock Analytics |
NEULAND LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NEULAND LABORATORIES | 8% |
20.3% |
258.5% |
SENSEX | -0.6% |
0.3% |
21.8% |
You may also like the below Video Courses